Tradipitant
VP-VLY-686-3304
Phase 3 small_molecule active
Quick answer
Tradipitant for Idiopathic or diabetic gastroparesis with moderate to severe nausea. is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Idiopathic or diabetic gastroparesis with moderate to severe nausea.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active